skip to content »

Molecular Virology and Microbiology

Houston, Texas

BCM has 25 departments and more than 90 research and patient-care centers.
Department of Molecular Virology and Microbiology
not shown on screen

Anthony W. Maresso, Ph.D.

« Previous | Faculty Index | Next »

Anthony W. Maresso, Ph.D.

Assistant Professor
Department of Molecular Virology & Microbiology

Research Interests

Pathogenesis of bacterial infections

Broadly speaking, bacterial pathogenesis refers to the study of the origin and progression of a disease which results from infection by bacteria. In some cases, specific disease symptoms are directly caused by the actions of the bacteria; in other cases, disease symptoms are a product of the immune system’s attempt to clear the pathogen. In both cases, there exists a dynamic interplay between the host and the invading bacteria which culminates in the survival of one but usually not the other. In an age where the remarkable adaptive and replicative ability of bacteria has lead to the rise of strains resistant to conventional antibiotics, modern medicine is faced with the challenge of discovering and validating new targets for drug development. Work in our laboratory attempts to understand this dynamic interplay on a mechanistic and reductionist level in hopes of acquiring information for the development of novel antibacterial agents.

Bacillus anthracis as a model bacterial pathogen

Fig 1. The B. anthracis lifecycle.
Fig 1. The B. anthracis lifecycle.

Bacillus anthracis, the etiological agent of the disease anthrax, has a storied interaction with humankind. One of the earliest descriptions of infectious disease during Egyptian times, the “plague of boils”, may have been caused by this pathogen.[1] The first careful studies of B. anthracis were performed by Robert Koch; indeed his work led to the elucidation of the B. anthracis life cycle, which was the foundation behind the development of the “postulates”.[2] The life cycle of B. anthracis is realized in ruminants and begins with the infectious particle, a spore, entering the host. A common theory is that spores are transported via phagocytes to the lymphatics.[3] In a poorly understood manner, spores germinate and vegetative cells enter the blood. Once initiated, the host succumbs very rapidly to the disease and, in the intervening weeks as the carcass decays, vegetative cells sporulate, thereby regenerating the infectious particle (Fig. 1).[4]

B. anthracis is an excellent model pathogen to study bacterial pathogenesis. Its genome harbors all the virulence determinants required to efficiently kill the host, including the ability to germinate in vivo, adhere to host tissues, produce toxins, evade the immune system, and sequester limiting nutrients for growth and replication. Since many of these virulence systems are similar in the mechanism of action to those of bacteria which cause more common infections, knowledge garnered herein is applicable to their understanding as well.

.Iron acquisition as a bacterial survival strategy

Fig 2. Hypothesis for heme acquisition in B. anthracis.
Fig 2. Hypothesis for heme acquisition
in B. anthracis

Iron is an essential nutrient used by almost all organisms. Bacterial pathogens must acquire iron in order to grow inside mammalian hosts. The host, however, limits the availability of free iron, thereby providing an effective defense strategy against infection. In response, bacteria have evolved clever ways to subvert host sequestration of iron. We have uncovered a cell wall-based heme acquisition system in B. anthracis with similarities to the iron-regulated surface determinant (Isd) locus (Fig. 2) in S. aureus.[5] The first three genes, ba-isdC, x1, and x2, contain NEAT (near iron transporter) domains, a conserved structural motif present in greater than 50 different Gram-positive bacteria.[6] We have determined Ba-IsdC is a heme-binding protein necessary for heme acquisition in B. anthracis.[7] Ba-IsdC is anchored to the cell wall by sortase (SrtB), a ubiquitous family of transpeptidases in Gram-positive bacteria which covalently append surface proteins to the peptidoglycan.[7], [8] The function of x1 and x2, both of which contain NEAT domains, is unknown. We hypothesized the smaller of the two, x1, encoded a secreted heme-scavenging protein, or “hemophore”, which acquires heme from host proteins during B. anthracis infection.

To test this hypothesis, we utilized a combination of genetic, biophysical and biochemical approaches aimed at determining the function of x1. Our studies indicate X1 is secreted from B. anthracis under iron-limiting conditions and expressed during anthrax disease. Purified X1 binds heme and is able to extract heme from mammalian hemoglobin (Hb). B. anthracis lacking x1 cannot effectively utilize Hb as a source of iron for growth. The mechanism of heme extraction from Hb is novel and is likely a property of all proteins which harbor NEAT domains, suggesting our work is applicable to iron acquisition in many Gram-positive pathogens. This is the first description of a secreted hemophore from Gram-positive bacteria and represents a target for therapeutic intervention.[9]

Small molecule inhibition of bacterial virulence systems

The elucidation of this heme-acquisition system in B. anthracis coincided with an initiative to discover inhibitors of sortase. The cell wall is indispensable for the survival of Gram-positive bacteria and lies at the interface of the bacterial/host interaction. Cell wall-anchored proteins are important in the infectious process by participating in diverse functions such as adhesion, immune system evasion, and iron acquisition. Sortase anchors these proteins to the cell wall via a conserved LPXTG-like motif at the C terminus of sortase substrates.[10] Approximately 200 homologs of sortase have been identified with ~ 900 potential substrates in over 50 different species of Gram-positive bacteria.[11] Loss of sortase leads to reductions in staphylococci, streptococci, and listerial pathogenesis in several animal models of infection, thus highlighting this transpeptidase as a target for anti-infective development.[12-14] Along these lines, we screened ~ 135, 000 small molecules for inhibition of S. aureus sortase A, the most prominent sortase isotype in Gram-positive genomes.[15]

Fig 3. X-ray structure of B. anthracis sortase B with AAEK1
Fig 3. X-ray structure of B. anthracis
sortase B with AAEK1. Shown is the
sortase B-AAEK1 adduct with
electrostatic potential of the active site.
The ionic pockets which flank the
inhibitor can be utilized to increase the
potency and specificity. The AAEK1
inhibitor atoms are color-coded as
follows: yellow = sulfur, red = oxygen
and blue = carbon.

Compounds which demonstrated the most drug-like properties were subjected to additional screens to yield the most potent and specific sortase inhibitors, which were grouped into classes according to their structure. The most promising compounds, the aryl b-aminoethyl ketones (AAEK), showed broad-spectrum inhibition of multiple families of sortases from both S. aureus and B. anthracis. The inactivation of sortase via the AAEKs was through a covalent, step-wise mechanism following the generation of a highly reactive intermediate in the sortase active site. Co-crystals of sortase with inhibitor allowed us to define structural factors on sortase mediating inhibitor binding and specificity (Fig. 3). This type of inactivation, termed mechanism-based inhibition, is found among on-market drugs and represents a promising candidate for further development.

Contact Information

Department of Molecular Virology & Microbiology
Baylor College of Medicine
One Baylor Plaza, MS BCM385
Houston, TX, 77030, U.S.A.

713-798-7369
maresso@bcm.edu

Education

Ph.D. - The Medical College of Wisconsin
Postdoctoral Fellowship - The University of Chicago

Additional information

Video Description
Positions
NIH Biosketch
Related Information
References cited on this page

Recent Publications (PubMed)

Students

Balderas, Miriam
Nguyen, Chinh Thi
Nobles, Christopher
Terwilliger, Austen


Related Information

National Institutes of Health - www.nih.gov
National Institute of Allergy and Infectious Disease - www.niaid.nih.gov
American Society of Microbiology - www.asm.org
Center for Disease Control - www.cdc.gov
Baylor Department of Molecular Virology and Microbiology - www.bcm.edu/molvir
Texas Medical Center - www.tmc.edu
Anthrax - www.cdc.gov/ncidod/DBMD/diseaseinfo/anthrax_g.htm
Antibiotic Resistance - www.cdc.gov/drugresistance
Category A Agents - http://emergency.cdc.gov/agent/agentlist-category.asp

References cited on this page

[1]

Hort, G. Zeitschrift für die Alttestamentliche Wissenschaft (1957).

[2]

Koch, R. Die Aetiologie der Milzbrand-Krankheit, begruendet auf die Entwicklungsgeschichte des Bacillus Anthracis. Beitraege zur Biologie der Pflanzen 2, 277-310 (1876).

[3]

Lincoln, R. E. et al. Role of the lymphatics in the pathogenesis of anthrax. J Infect Dis 115, 481-94 (1965).

[4]

Jensen, G. B., Hansen, B. M., Eilenberg, J. & Mahillon, J. The hidden lifestyles of Bacillus cereus and relatives. Environ Microbiol 5, 631-40 (2003).

[5]

Maresso, A. W. & Schneewind, O. Iron acquisition and transport in Staphylococcus aureus. Biometals 19, 193-203 (2006).

[6]

Andrade, M. A., Ciccarelli, F. D., Perez-Iratxeta, C. & Bork, P. NEAT: a domain duplicated in genes near the components of a putative Fe3+ siderophore transporter from Gram-positive pathogenic bacteria. Genome Biol 3, RESEARCH0047 (2002).

[7]

Maresso, A. W., Chapa, T. J. & Schneewind, O. Surface protein IsdC and sortase B are required for heme-iron scavenging of Bacillus anthracis. J Bacteriol 188, 8145-8152 (2006).

[8]

Mazmanian, S. K., Liu, G., Ton-That, H. & Schneewind, O. Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 285, 760-763 (1999).

[9]

Maresso, A. W., Garufi, G. & Schneewind, O. Bacillus anthracis secretes proteins that mediate heme acquisition from hemoglobin. PLoS Pathog 4, e1000132 (2008).

[10]

Mazmanian, S. K. & Schneewind, O. in Bacillus subtilis and its closest relatives (eds. Sonenshine, A., Losick, R. & Hoch, J.) 57-70 (ASM Press, New York, 2002).

[11]

Comfort, D. & Clubb, R. T. A comparative genome analysis idenitifies distinct sorting pathways in gram-positive bacteria. Infect. Immun. 72, 2710-2722 (2004).

[12]

Mazmanian, S. K., Liu, G., Jensen, E. R., Lenoy, E. & Schneewind, O. Staphylococcus aureus mutants defective in the display of surface proteins and in the pathogenesis of animal infections. Proc. Natl. Acad. Sci. USA 97, 5510-5515 (2000).

[13]

Paterson, G. K. & Mitchell, T. J. The role of Streptococcus pneumoniae sortase A in colonisation and pathogenesis. Microbes Infect (2005).

[14]

Garandeau, C. et al. The sortase SrtA of Listeria monocytogenes is involved in processing of internalin and in virulence. Infect. Immun. 70, 1382-1390 (2002).

[15]

Maresso, A. W., Wu, R., Kern, J.W., Zhang, R., Janik, D., Missiakas, D.M., Duban, M.E., Joachimiak, A., Schneewind, O. Activation of Inhibitors by Sortase Triggers Irreversible Modification of the Active Site. Journal of Biological Chemistry (2007).


Positions

Research Technician I
This posting seeks an outstanding candidate to perform basic research into the mechanisms by which pathogenic bacteria acquire iron during the infection of a mammalian host. The candidate will be expected to develop a scientific investigation, under the supervision of the laboratory head, into the biochemistry and molecular biology of bacterial iron transport proteins, followed by cellular and animal studies examining the interplay of these proteins with the host during infection. The candidate will also be expected to perform basic laboratory duties, including the purchasing and ordering of reagents, oversee the maintenance and care of laboratory equipment, and help direct general research activities. Knowledge of basic bacteriology, molecular cloning, protein expression and purification, and animal experimentation is a plus. The candidate will become a member of Molecular Virology and Microbiology, a large, successful, and diverse Department with nearly 40 full-time faculty and physician-scientists. This is a wonderful opportunity to become involved in exciting infectious disease research at one of the premier medical schools in the United States.

Please visit https://www.medschooljobs.org to begin the formal application process or send CV with three references directly to:

Anthony Maresso, Ph.D.
Assistant Professor,
MVM
One Baylor Plaza,
BCM280
Houston, Tx, 77030
or email (preferred) to maresso@bcm.edu